LMNL — Liminal BioSciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Liminal BioSciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	7.39	61.3	45.1	108	37.1
Net Total Accounts Receivable
Net Total Receivables	20	13.3	3.9	1.07	1.18
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	40.8	94.8	73	115	41.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	41.1	54.7	27.3	7.09	5.49
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	103	165	118	126	50.5
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	35.7	31.3	23.8	18.5	10.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	159	62.9	94.7	83.4	14.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-56.6	102	23.1	42.6	36.2
Total Liabilities & Shareholders' Equity	103	165	118	126	50.5
Total Common Shares Outstanding